Effects of Panax Notoginseng (Chinese Ginseng) and Acute Exercise on Postprandial Glycemia in Non-diabetic Adults
The purpose of this study is to determine whether Panax Notoginseng (PNG) taken for 3 days and one 30-min cycling exercise can reduce postprandial hyperglycemia after ingesting a 75-mg oral glucose solution (OGTT) in untrained non-diabetic men, age 20-45 years. We randomly assigned 52 men to: 1) gin...
Saved in:
Published in | Journal of complementary & integrative medicine Vol. 8; no. 1 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Germany
De Gruyter
04.01.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The purpose of this study is to determine whether Panax Notoginseng (PNG) taken for 3 days and one 30-min cycling exercise can reduce postprandial hyperglycemia after ingesting a 75-mg oral glucose solution (OGTT) in untrained non-diabetic men, age 20-45 years. We randomly assigned 52 men to: 1) ginseng (G) + exercise (G+Ex, n=14), 2) ginseng (G, n=13), 3) placebo (C) + exercise (C+Ex, n=12), and 4) placebo control groups (C, n=13). The G and C groups took a daily 3g dose of PNG and cornstarch-placebo supplement for 3 days, respectively. The exercise groups also performed a 30-min cycling exercise on day 3 prior to OGTT. The daily 3g-dose of PNG supplementation significantly lowered postprandial plasma glucose (PG) concentration at 30 min post-OGTT in the G group, compared with C (mean Δ±SE: G vs. C = 26.3±11 mg/dl, p<0.05) and PG area under the curve (PG-AUC0-90) in the G and G+Ex groups, relative to the C (G vs. C = 96.5±42 and G+Ex vs. C = 85.2±41 mg/dl, both p<0.05). We conclude that a daily 3g-dose of PNG taken for 3 days, not one acute bout of 30-min cycling exercise at 60% VO2max, lowered postprandial glycemia at 30-min post-OGTT and PG-AUC 0-90 min in non-diabetic men, age 20-45 years. |
---|---|
Bibliography: | ark:/67375/QT4-ZVSH5CT8-8 istex:BD90604C074D1364711D76F00BBA2C6A36B51BDF 1553-3840.1402.pdf ArticleID:1553-3840.1402 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-News-1 ObjectType-Feature-3 content type line 23 |
ISSN: | 1553-3840 1553-3840 |
DOI: | 10.2202/1553-3840.1402 |